NCT01198574

Brief Summary

Anemia and vitamin A deficiency (VAD) are major nutritional problems in the world and also in Myanmar. Both nutrient deficiencies result from interaction of several causal factors, and a better understanding of the etiology to interpret the prevalence and to formulate appropriate measures to reduce these deficiencies is necessary. There is a growing concern on the role of sub-clinical inflammation on the nutritional status indicators during the nutritional status assessment. However, there is lack of information on the role of inflammation on the iron supplementation. The adolescent period is a window of opportunity to improve the preconceptional iron status of the girls and recently gained much attention. The purpose of the study is to understand the role of inflammation on iron and vitamin A status during iron and vitamin A supplementation. The findings will show the extent to which iron supplementation has been hampered by inflammation and to formulate the necessary measures to overcome the interference.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
402

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Jul 2010

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 10, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

May 16, 2012

Completed
Last Updated

May 22, 2012

Status Verified

May 1, 2012

Enrollment Period

5 months

First QC Date

September 8, 2010

Results QC Date

December 31, 2011

Last Update Submit

May 15, 2012

Conditions

Keywords

anemiairon supplementationsub-clinical inflammationadolescents

Outcome Measures

Primary Outcomes (3)

  • Haemoglobin Level

    Haemoglobin level (g/L) measured by cyanmethaemoglobin method

    at week 0, week 6 and week12

  • Status of Tissue Iron Store

    Tissue iron store was measured by serum ferritin

    at week 0, week 6 and week12

  • Status of Cellular Iron Deficiency

    Cellular Iron deficiency status is also measured by serum transferrin receptor

    at week 0, week 6 and week12

Study Arms (4)

Iron group

EXPERIMENTAL
Dietary Supplement: Iron group

Vitamin A group

EXPERIMENTAL

Vitamin A group

Dietary Supplement: Vitamin A group

Iron and Vitamin A group

EXPERIMENTAL

Iron and Vitamin A group

Dietary Supplement: Iron and vitamin A group

Placebo group

EXPERIMENTAL

Placebo group with folic acid

Dietary Supplement: Placebo group

Interventions

Iron groupDIETARY_SUPPLEMENT

Ferrous fumarate, 60 mg, weekly dose

Also known as: Iron supplement
Iron group
Vitamin A groupDIETARY_SUPPLEMENT

Retinol, weekly dose, 15,000 IU

Also known as: Vitamin A supplement
Vitamin A group
Iron and vitamin A groupDIETARY_SUPPLEMENT

Ferrous fumarate, Retinol combination group, weekly dose

Also known as: Iron and Vitamin A supplement
Iron and Vitamin A group
Placebo groupDIETARY_SUPPLEMENT

folic acid only as placebo group

Also known as: Placebo group, folic acid only
Placebo group

Eligibility Criteria

Age12 Years - 19 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • adolescent girls (age 12-19 years)
  • already experienced menarche
  • anemic girls (Hb\<120 g/L)
  • no known illness (apparently healthy)
  • free from haemoglobinopathy
  • No regular consumption of iron and vitamin A supplement during the last 3 months

You may not qualify if:

  • subjects with chronic illness
  • subjects with severe anaemia
  • who do not give the consents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nyaung Done Township

Pathein, Ayeyarwady Region, Burma

Location

Related Publications (9)

  • Thurnham DI, McCabe LD, Haldar S, Wieringa FT, Northrop-Clewes CA, McCabe GP. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. Am J Clin Nutr. 2010 Sep;92(3):546-55. doi: 10.3945/ajcn.2010.29284. Epub 2010 Jul 7.

    PMID: 20610634BACKGROUND
  • Mburu AS, Thurnham DI, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV+ Kenyan adults. J Nutr. 2008 Mar;138(3):613-9. doi: 10.1093/jn/138.3.613.

    PMID: 18287375BACKGROUND
  • Thurnham DI, Mburu AS, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. Using plasma acute-phase protein concentrations to interpret nutritional biomarkers in apparently healthy HIV-1-seropositive Kenyan adults. Br J Nutr. 2008 Jul;100(1):174-82. doi: 10.1017/S0007114507883012. Epub 2008 Jan 4.

    PMID: 18177514BACKGROUND
  • Thurnham DI, Mburu AS, Mwaniki DL, De Wagt A. Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc. 2005 Nov;64(4):502-9. doi: 10.1079/pns2005468.

    PMID: 16313694BACKGROUND
  • Thurnham DI. Vitamin A, iron, and haemopoiesis. Lancet. 1993 Nov 27;342(8883):1312-3. doi: 10.1016/0140-6736(93)92239-p. No abstract available.

    PMID: 7901629BACKGROUND
  • Angeles-Agdeppa I, Schultink W, Sastroamidjojo S, Gross R, Karyadi D. Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents. Am J Clin Nutr. 1997 Jul;66(1):177-83. doi: 10.1093/ajcn/66.1.177.

    PMID: 9209187BACKGROUND
  • Tee ES, Kandiah M, Awin N, Chong SM, Satgunasingam N, Kamarudin L, Milani S, Dugdale AE, Viteri FE. School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls. Am J Clin Nutr. 1999 Jun;69(6):1249-56. doi: 10.1093/ajcn/69.6.1249.

    PMID: 10357747BACKGROUND
  • Htet MK, Fahmida U, Dillon D, Akib A, Utomo B, Thurnham DI. The influence of vitamin A status on iron-deficiency anaemia in anaemic adolescent schoolgirls in Myanmar. Public Health Nutr. 2014 Oct;17(10):2325-32. doi: 10.1017/S1368980013002723. Epub 2013 Oct 16.

  • Htet MK, Dillon D, Akib A, Utomo B, Fahmida U, Thurnham DI. Microcytic anaemia predominates in adolescent school girls in the delta region of Myanmar. Asia Pac J Clin Nutr. 2012;21(3):411-5.

Related Links

MeSH Terms

Conditions

Anemia

Interventions

Iron-Dextran ComplexIron

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Coordination ComplexesOrganic ChemicalsDextransGlucansPolysaccharidesCarbohydratesMetals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Results Point of Contact

Title
Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar
Organization
South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition

Study Officials

  • Min Kyaw Htet, PhD

    (1) South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition, University of Indonesia, (2) Ministry of Health, Myanmar

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

September 8, 2010

First Posted

September 10, 2010

Study Start

July 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

May 22, 2012

Results First Posted

May 16, 2012

Record last verified: 2012-05

Locations